Approval · Notice of Compliance 38382 · 2026
IQIRVO: Notice of Compliance 38382
Issued September 29, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38382
- Date
- September 29, 2026
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IQIRVO | Not yet assigned | — |
Medicinal ingredients
- ELAFIBRANOR 80 MG per TAB